Почетна › Неуробластом › Њујорк
Kliničke studije za Неуробластом u državi Њујорк
15 studija za Неуробластом traži učesnike na lokacijama u državi Њујорк.
Gradovi u državi Њујорк
Zvanični tekst studije (na engleskom)
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Columbia University Medical Center, New York
Тражи се учесник
До 17 година · Оба пола · Ажурирано 13. 11. 2026. · NCT06831552A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 2Здраве особе су добродошле
Сви узрасти · Оба пола · Ажурирано 10. 11. 2026. · NCT04936529A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
- Memorial Sloan Kettering Suffolk-Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- и још 1
Тражи се учесникФаза 2
Сви узрасти · Оба пола · Ажурирано 9. 11. 2026. · NCT06057948Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
- Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 1/2
Узраст од 1 до 30 · Оба пола · Ажурирано 6. 11. 2026. · NCT07437963Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Albany Medical Center, Albany
- Roswell Park Cancer Institute, Buffalo
- NYU Langone Hospital - Long Island, Mineola
- и још 7
Тражи се учесникФаза 3
До 30 година · Оба пола · Ажурирано 30. 10. 2026. · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Memorial Sloan Kettering Cancer Center ( Site 1010), New York
- New York Medical College ( Site 1023), Valhalla
Тражи се учесникФаза 1/2
6 Months – 25 Years · Оба пола · Ажурирано 30. 10. 2026. · NCT06395103Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
- Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 5. 10. 2026. · NCT00588068N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
- Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 2
18 Months – 19 Years · Оба пола · Ажурирано 28. 8. 2026. · NCT06528496Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- Roswell Park Cancer Institute, Buffalo
- и још 8
Тражи се учесникФаза 3
365 Days – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT04851119SPEARHEAD-3 Pediatric Study
- Memorial Sloan Kettering Kids, New York
Тражи се учесникФаза 1/2
Узраст од 2 до 21 · Оба пола · Ажурирано 11. 8. 2026. · NCT05642455Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 2
Узраст 1 и старији · Оба пола · Ажурирано 29. 5. 2026. · NCT00107289Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
- New York Medical College, Valhalla
Тражи се учесникФаза 1
Узраст од 1 до 30 · Оба пола · Ажурирано 15. 4. 2026. · NCT04308330Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
- New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
Тражи се учесникФаза 2
Узраст од 1 до 50 · Оба пола · Ажурирано 13. 3. 2026. · NCT01804634A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital at Montefiore, The Bronx
Тражи се учесникФаза 2
18 Months – 40 Years · Оба пола · Ажурирано 12. 8. 2025. · NCT05135975Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.